Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

PIN18 THE IMPACT OF PEDIATRIC ADVERSE EVENTS ON THE COST-EFFECTIVENESS OF OSELTAMIVIR

Autor: Lavelle, TA, Uyeki, TM, Prosser, L

Publikováno v: In Value in Health 2008 11(3):A97-A97

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Paving the path for implementation of clinical genomic sequencing globally: Are we ready?

Autor: Marshall DA; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta T2N 4Z6, Canada.; Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Alberta T2N 4N1, Canada., Hua N; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta T2N 4Z6, Canada., Buchanan J; Health Economics and Policy Research Unit, Centre for Evaluation and Methods, Wolfson Institute of Population Health, Queen Mary University of London, London E1 2AB, United Kingdom., Christensen KD; PRecisiOn Medicine Translational Research (PROMoTeR) Center, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA 02215, United States., Frederix GWJ; Epidemiology and Health Economics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, 3584 CG Utrecht, The Netherlands., Goranitis I; Health Economics Unit, Centre for Health Policy, Melbourne School of Population and Global Health, University of Melbourne, Parkville, Victoria 3010, Australia.; Australian Genomics, Parkville, Victoria 3052, Australia., Ijzerman M; University of Melbourne Centre for Cancer Research, University of Melbourne, Melbourne, Victoria 3000, Australia.; Erasmus School of Health Policy & Management, Eramus University Rotterdam, 3062 PA Rotterdam, The Netherlands., Jansen JP; Center for Translational and Policy Research on Precision Medicine (TRANSPERS), Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, San Francisco, CA 94158, United States., Lavelle TA; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA 02111, United States., Regier DA; Canadian Centre for Applied Research in Cancer Control, Cancer Control Research, BC Cancer Research Institute, Vancouver, British Columbia V5Z 1L3, Canada.; School of Population and Public Health, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada., Smith HS; PRecisiOn Medicine Translational Research (PROMoTeR) Center, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA 02215, United States., Ungar WJ; Program of Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario M5G 0A4, Canada.; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario M5T 3M6, Canada., Weymann D; School of Population and Public Health, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada.; Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada., Wordsworth S; Health Economics Research Centre, Nuffield Department of Population Health and NIHR Biomedical Research Centre, University of Oxford, Oxford OX3 7LF, United Kingdom., Phillips KA; Center for Translational and Policy Research on Precision Medicine (TRANSPERS), Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, San Francisco, CA 94158, United States.; Health Affairs Scholar Emerging & Global Health Policy, Health Affairs, Washington, DC 20036, United States.

Publikováno v: Health affairs scholar [Health Aff Sch] 2024 Apr 29; Vol. 2 (5), pp. qxae053. Date of Electronic Publication: 2024 Apr 29 (Print Publication: 2024).

Pediatric Genomic Medicine: Value, Implementation, and Access.

Autor: Lavelle TA; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts. Electronic address: tara.lavelle@tuftsmedicine.org., Smith HS; PRecisiOn Medicine Translational Research (PROMoTeR) Center, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts.

Publikováno v: Clinical therapeutics [Clin Ther] 2023 Aug; Vol. 45 (8), pp. 687-689. Date of Electronic Publication: 2023 Aug 08.